Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Immunotech Biopharm Ltd    6978   KYG4721A1004

IMMUNOTECH BIOPHARM LTD

(6978)
  Report
End-of-day quote. End-of-day quote Hong Kong Stock Exchange - 11/26
9.93 HKD   -1.10%
 SummaryChartsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
9.8 9.97 10.04 9.93 9.7 Last
1626628 864000 1946000 316000 263000 Volume
+4.48% +1.73% +0.70% -1.10% -2.32% Change
Financials
Sales 2020 - - -
Net income 2020 -232 M -35,4 M -35,4 M
Net Debt 2020 - - -
P/E ratio 2020 -18,3x
Yield 2020 -
Sales 2021 - - -
Net income 2021 -142 M -21,6 M -21,6 M
Net Debt 2021 - - -
P/E ratio 2021 -29,4x
Yield 2021 -
Capitalization 4 234 M 644 M 644 M
Capi. / Sales 2020 -
Capi. / Sales 2021 -
Nbr of Employees 207
Free-Float 17,2%
More Financials
Company
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its... 
More about the company
All news about IMMUNOTECH BIOPHARM LTD

- No features available -

More news
News in other languages on IMMUNOTECH BIOPHARM LTD

- No features available -

More news
Chart IMMUNOTECH BIOPHARM LTD
Duration : Period :
Immunotech Biopharm Ltd Technical Analysis Chart | 6978 | KYG4721A1004 | MarketScreener
Technical analysis trends IMMUNOTECH BIOPHARM LTD
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 13,00 CNY
Last Close Price 8,23 CNY
Spread / Highest target 58,1%
Spread / Average Target 58,1%
Spread / Lowest Target 58,1%
EPS Revisions
Managers
NameTitle
Yu Wang CEO, Co-CTO & Executive Director
Zheng Tan Chairman
Ning Yang Chief Financial Officer
Ho-un Kim Co-Chief Technology Officer
Yu Zhang Chief Scientist
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOTECH BIOPHARM LTD0.00%644
WUXI APPTEC CO., LTD.56.53%37 916
BEIGENE, LTD.72.47%26 060
NEUROCRINE BIOSCIENCES, INC.-11.51%8 928
SPRINGWORKS THERAPEUTICS, INC.76.67%3 259
AXSOME THERAPEUTICS, INC.-27.26%2 808